How have INBS shares performed in 2024?

Intelligent Bio Solutions' stock was trading at $4.0548 at the start of the year. Since then, INBS stock has decreased by 32.4% and is now trading at $2.74. View the best growth stocks for 2024 here .

Are investors shorting Intelligent Bio Solutions?

Intelligent Bio Solutions saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 71,600 shares, a drop of 21.3% from the March 15th total of 91,000 shares. Based on an average daily trading volume, of 3,150,000 shares, the short-interest ratio is presently 0.0 days. Approximately 2.5% of the company's shares are sold short. View Intelligent Bio Solutions' Short Interest .

When is Intelligent Bio Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our INBS earnings forecast .

How were Intelligent Bio Solutions' earnings last quarter?

Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its quarterly earnings data on Friday, February, 9th. The company reported ($2.07) earnings per share for the quarter, beating the consensus estimate of ($3.24) by $1.17. The firm earned $0.76 million during the quarter. Intelligent Bio Solutions had a negative net margin of 544.63% and a negative trailing twelve-month return on equity of 266.16%.

When did Intelligent Bio Solutions' stock split?

Intelligent Bio Solutions's stock reverse split before market open on Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What guidance has Intelligent Bio Solutions issued on next quarter's earnings?

Intelligent Bio Solutions updated its third quarter 2024 earnings guidance on Thursday, April, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of 820000.000-820000.000, compared to the consensus revenue estimate of $1.2 million.

How do I buy shares of Intelligent Bio Solutions?

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free INBS Stock Alerts

$2.74

-0.06 (-2.14%)

(As of 04/19/2024 ET)

Compare

Today's Range: $2.68
▼
$2.86
50-Day Range: $2.68
▼
$6.00
52-Week Range: $2.28
▼
$49.20

Volume: 57,865 shs
Average Volume: 2.70 million shs
Market Capitalization: $7.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Intelligent Bio Solutions alerts:

Intelligent Bio Solutions MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
2.53% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.44
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($3.67) to ($1.25) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.69 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Intelligent Bio Solutions.

5.0

Short Interest

Percentage of Shares Shorted
2.53% of the float of Intelligent Bio Solutions has been sold short.
Short Interest Ratio / Days to Cover
Intelligent Bio Solutions has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Intelligent Bio Solutions has recently decreased by 21.32%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Intelligent Bio Solutions does not currently pay a dividend.
Dividend Growth
Intelligent Bio Solutions does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for INBS.

1.9

News and Social Media Coverage

News Sentiment
Intelligent Bio Solutions has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Intelligent Bio Solutions this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for INBS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.28% of the stock of Intelligent Bio Solutions is held by insiders.
Percentage Held by Institutions
Only 32.97% of the stock of Intelligent Bio Solutions is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($3.67) to ($1.25) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Intelligent Bio Solutions is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Intelligent Bio Solutions is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Intelligent Bio Solutions has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

INBS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INBS Stock News Headlines

April 19, 2024 | americanbankingnews.com

Intelligent Bio Solutions (NASDAQ:INBS) Trading 4.5% Higher

April 18, 2024 | finanznachrichten.de

Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 18, 2024 | globenewswire.com

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results

April 11, 2024 | globenewswire.com

Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader

April 10, 2024 | americanbankingnews.com

Head-To-Head Analysis: enVVeno Medical (NASDAQ:NVNO) & Intelligent Bio Solutions (NASDAQ:INBS)

March 26, 2024 | globenewswire.com

Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

March 12, 2024 | globenewswire.com

Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 11, 2024 | msn.com

Intelligent BIO Ekes up on Private Placement

March 11, 2024 | markets.businessinsider.com

Intelligent Bio Solutions Announces $10.1 Mln Private Placement

March 11, 2024 | finance.yahoo.com

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

March 11, 2024 | globenewswire.com

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

March 1, 2024 | globenewswire.com

Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024

February 29, 2024 | msn.com

Intelligent Bio Solutions seeks 510(k) approval with drug screening study

February 28, 2024 | finanznachrichten.de

Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway

February 28, 2024 | globenewswire.com

Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway

February 20, 2024 | benzinga.com

Peering Into Intelligent Bio Solutions's Recent Short Interest

February 16, 2024 | finance.yahoo.com

Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity Requirement

February 16, 2024 | globenewswire.com

Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders' Equity Requirement

February 11, 2024 | finance.yahoo.com

Intelligent Bio Solutions Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

February 9, 2024 | finance.yahoo.com

Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights

February 5, 2024 | msn.com

Why Is Intelligent Bio Solutions Stock Tumbling Today?

February 5, 2024 | finance.yahoo.com

Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds

February 2, 2024 | msn.com

Why Intelligent Bio Solutions Shares Are Skyrocketing Today

February 2, 2024 | markets.businessinsider.com

Intelligent Bio Solutions Expects Higher Q2 Revenue, Stock Up In Pre-Market

February 2, 2024 | finance.yahoo.com

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results

See More Headlines

Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/09/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:INBS
CUSIP: N/A
CIK: 1725430
Web: gbs.inc
Phone: 646-828-8258
Fax: N/A
Employees: 51
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($106.1510)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,630,000.00
Net Margins: -544.63%
Pretax Margin: -546.02%
Return on Equity: -266.16%
Return on Assets: -96.52%

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 0.57
Quick Ratio: 0.39

Sales & Book Value

Annual Sales: $1.26 million
Price / Sales: 6.18
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $18.99 per share
Price / Book: 0.14

Miscellaneous

Outstanding Shares: 2,840,000
Free Float: 2,836,000
Market Cap: $7.78 million
Optionable: Not Optionable
Beta: 4.82

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Harry Simeonidis (Age 57)
President & CEO
Comp: $310.79k
Mr. Spiro Kevin Sakiris B.Bus (Age 62)
C.A., CA, Dip Law, Chief Financial Officer
Comp: $274.43k
Ms. Victoria Gavrilenko (Age 41)
Operations Manager
Comp: $45k
Mr. Alex Arzeno
VP of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

INBS Stock Analysis - Frequently Asked Questions

How have INBS shares performed in 2024?: Intelligent Bio Solutions' stock was trading at $4.0548 at the start of the year. Since then, INBS stock has decreased by 32.4% and is now trading at $2.74.
View the best growth stocks for 2024 here.
Are investors shorting Intelligent Bio Solutions?: Intelligent Bio Solutions saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 71,600 shares, a drop of 21.3% from the March 15th total of 91,000 shares. Based on an average daily trading volume, of 3,150,000 shares, the short-interest ratio is presently 0.0 days. Approximately 2.5% of the company's shares are sold short.
View Intelligent Bio Solutions' Short Interest.
When is Intelligent Bio Solutions' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our INBS earnings forecast.
How were Intelligent Bio Solutions' earnings last quarter?: Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its quarterly earnings data on Friday, February, 9th. The company reported ($2.07) earnings per share for the quarter, beating the consensus estimate of ($3.24) by $1.17. The firm earned $0.76 million during the quarter. Intelligent Bio Solutions had a negative net margin of 544.63% and a negative trailing twelve-month return on equity of 266.16%.

When did Intelligent Bio Solutions' stock split?: Intelligent Bio Solutions's stock reverse split before market open on Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.
What guidance has Intelligent Bio Solutions issued on next quarter's earnings?: Intelligent Bio Solutions updated its third quarter 2024 earnings guidance on Thursday, April, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of 820000.000-820000.000, compared to the consensus revenue estimate of $1.2 million.
How do I buy shares of Intelligent Bio Solutions?: Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INBS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial